Related references
Note: Only part of the references are listed.Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Geoffrey L. Uy et al.
BLOOD (2021)
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy
Semjon Willier et al.
BLOOD (2021)
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy
Yun Wang et al.
CLINICAL CANCER RESEARCH (2021)
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBLeActivated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
Lara Maria Gomez Garcia et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies
Federico Lussana et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy
Sophia Khaldoyanidi et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
Satyen H. Gohil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
The Multiple Potential Biomarkers for Predicting Immunotherapy Response-Finding the Needle in the Haystack
Tamiem Adam et al.
CANCERS (2021)
Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment
Xianwen Ren et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
CAR-T treatment of pediatric AML: a long and winding road
Barbara De Moerloose
BLOOD (2021)
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale et al.
NATURE MEDICINE (2021)
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer
Dristhi Ragoonanan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
Julian Swatler et al.
CANCERS (2021)
T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments
Naval Daver et al.
LEUKEMIA (2021)
Towards precision medicine for AML
Hartmut Dohner et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
Stephanie Sendker et al.
CANCERS (2021)
Editorial: The Biological Landscape of Immunotherapy in AML
Alessandro Isidori et al.
FRONTIERS IN ONCOLOGY (2021)
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
Alessandro Isidori et al.
FRONTIERS IN ONCOLOGY (2021)
Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success
Ilaria M. Michelozzi et al.
CANCERS (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
Vanessa Innao et al.
CURRENT ONCOLOGY (2021)
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation
Amy Y. Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Peripheral T cell expansion predicts tumour infiltration and clinical response
Thomas D. Wu et al.
NATURE (2020)
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
Dana Stenger et al.
BLOOD (2020)
Immunogenomic Landscape of Hematological Malignancies
Olli Dufva et al.
CANCER CELL (2020)
AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances
Kristin L. Koenig et al.
GENES (2020)
Risk-associated alterations in marrow T cells in pediatric leukemia
Jithendra Kini Bailur et al.
JCI INSIGHT (2020)
Immune profiling of pediatric solid tumors
Rachael L. Terry et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia
Adam J. Lamble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Vadakekolathu et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?
Jan Philipp Bewersdorf et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Siwen Hu-Lieskovan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival
Oscar Bruck et al.
BLOOD ADVANCES (2020)
Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy
Sara Valpione et al.
NATURE CANCER (2020)
State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours-a German radiation oncology survey
Lukas Kaesmann et al.
EUROPEAN JOURNAL OF CANCER (2019)
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets
Maximilian Stahl et al.
CURRENT ONCOLOGY REPORTS (2019)
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
Maddalena Noviello et al.
NATURE COMMUNICATIONS (2019)
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
Nirav N. Shah et al.
FRONTIERS IN ONCOLOGY (2019)
Clonal replacement of tumor-specific T cells following PD-1 blockade
Kathryn E. Yost et al.
NATURE MEDICINE (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
Jian Zhang et al.
GENOME MEDICINE (2019)
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia
Darina Ocadlikova et al.
FRONTIERS IN ONCOLOGY (2019)
The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy
Lourdes M. Mendez et al.
FRONTIERS IN ONCOLOGY (2019)
The Graft-Versus-Leukemia Effect in AML
Connor Sweeney et al.
FRONTIERS IN ONCOLOGY (2019)
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
Patrick Williams et al.
CANCER (2019)
CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping
Anne E. Bras et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2019)
Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality
A. M. J. Reedijk et al.
LEUKEMIA (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Naval Daver et al.
CANCER DISCOVERY (2019)
Opportunities for immunotherapy in childhood acute myeloid leukemia
Adam J. Lamble et al.
BLOOD ADVANCES (2019)
The pro-tumorigenic host response to cancer therapies
Yuval Shaked
NATURE REVIEWS CANCER (2019)
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
Hamid Bolouri et al.
NATURE MEDICINE (2018)
Tyrosine kinase inhibitors and immune checkpoint blockade in allogeneic hematopoietic cell transplantation
Robert J. Soiffer et al.
BLOOD (2018)
Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia
Franziska Blaeschke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein et al.
IMMUNITY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway
Min Wang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Patrick Danaher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity
Adam J. Lamble et al.
FRONTIERS IN ONCOLOGY (2018)
Nivolumab (Nivo) maintenance (maint) in high-risk (HR) acute myeloid leukemia (AML) patients.
Tapan M. Kadia et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
Combining immune Checkpoint inhibitors with Conventional Cancer Therapy
Yiyi Yan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias
Shahzya Chaudhury et al.
NATURE COMMUNICATIONS (2018)
Maintenance Therapy With Interleukin-2 for Childhood AML Results of ELAM02 Phase III Randomized Trial
Arnaud Petit et al.
HEMASPHERE (2018)
Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy
Hanna A. Knaus et al.
JCI INSIGHT (2018)
First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial
Fang Liu et al.
BLOOD (2018)
Dissecting the Immune Landscape of Acute Myeloid Leukemia
Jan Davidson-Moncada et al.
BIOMEDICINES (2018)
Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect
Guillermo Orti et al.
EXPERIMENTAL HEMATOLOGY (2017)
Discovery and application of immune biomarkers for hematological malignancies
Dimitrios Zafeiris et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Hagop Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Martin Lauss et al.
NATURE COMMUNICATIONS (2017)
Gene expression markers of Tumor Infiltrating Leukocytes
Patrick Danaher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers
Robbie G. Majzner et al.
CANCER CELL (2017)
Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors
Anja Derer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation
Rick Admiraal et al.
BLOOD (2016)
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
C. Michel Zwaan et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Evolution of the immune system in humans from infancy to old age
A. Katharina Simon et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
Immune Checkpoint Inhibitors in Melanoma Provide the Cornerstones for Curative Therapies
Alexander M. M. Eggermont et al.
SEMINARS IN ONCOLOGY (2015)
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis
Rick Admiraal et al.
LANCET HAEMATOLOGY (2015)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Clinical significance of Treg cell frequency in acute myeloid leukemia
Wenjuan Yang et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
Fernando Ulloa-Montoya et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
Omission of in vivo T-cell depletion promotes rapid expansion of naive CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant
Robert Chiesa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells
Christopher G. Kanakry et al.
BLOOD (2011)
Targeted Therapy With the T-Cell-Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Max S. Topp et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis
A Saudemont et al.
BLOOD (2004)
Share Paper
